The Minimal Residual Disease Market is experiencing remarkable growth as healthcare providers increasingly adopt highly sensitive diagnostic technologies to detect residual cancer cells following treatment. Minimal residual disease (MRD) assessment has become an essential component of modern oncology, enabling physicians to identify microscopic levels of disease that remain undetectable through...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek